Volume 127, Issue 5 pp. 429-433
ORIGINAL ARTICLE

Osmium absorption after osmium tetroxide skin and eye exposure

Natalie Friedova

Corresponding Author

Natalie Friedova

Internal Department, Third Faculty of Medicine Charles University, Thomayer Hospital, Prague, Czech Republic

Correspondence

Natalie Friedova, Internal Department, Third Faculty of Medicine Charles University, Thomayer Hospital, Prague, Czech Republic.

Email: [email protected]

Search for more papers by this author
Daniela Pelclova

Daniela Pelclova

Toxicological Information Centre, Department of Occupational Medicine, First Faculty of Medicine, Charles University, General University Hospital Prague, Prague, Czech Republic

Search for more papers by this author
Nikola Obertova

Nikola Obertova

Toxicological Information Centre, Department of Occupational Medicine, First Faculty of Medicine, Charles University, General University Hospital Prague, Prague, Czech Republic

Search for more papers by this author
Karel Lach

Karel Lach

Institute of Public Health Ostrava, Ostrava, Czech Republic

Search for more papers by this author
Katerina Kesslerova

Katerina Kesslerova

Ophthalmological Department, Thomayer Hospital, Prague, Czech Republic

Search for more papers by this author
Pavel Kohout

Pavel Kohout

Internal Department, Third Faculty of Medicine Charles University, Thomayer Hospital, Prague, Czech Republic

Search for more papers by this author
First published: 11 June 2020
Citations: 12

Abstract

Osmium tetroxide is a strong oxidizing agent used in electron microscopy. Eye exposure may cause severe burns, and after inhalation or ingestion damage to the respiratory or gastrointestinal tract occurs. Exposure to osmium and its compounds is extremely rare. We present a case of a 32-year-old female stained by 9 mL of 2% osmium tetroxide in acetone during an accident in the laboratory, with rare dermal and ocular findings. Due to lack of data in toxicological databases and the absence of antidote, the therapy was symptomatic. Osmium was detected in serum 19 hours later (0.22 μg/L) and in urine during the 15-hour collection (three samples—7.05, 1.65 and 8.45 μg/L). In blood serum on admission, after 1 and 2 days after exposure, the levels of iron (28.2, 39.8 and 50.5 μmol/L; reference range 5.8-34.5 μmol/L) and transferrin receptor/ferritine were elevated. To our knowledge, this is the first paper documenting a significant absorption from the skin and potentially from the eye conjunctiva, based on serum and urine analysis. The relationship between increased iron in blood and exposure has not been described yet, and the mechanism remains unknown. The patient is being followed up for the unknown long-term effects.

CONFLICT OF INTEREST

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the manuscript. The patient gave her informed consent and signed agreement with this description of her case.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.